The End of an Era: EQT’s €10.8 Billion Acquisition Marks a New Chapter for Qiagen
In a monumental development that reshapes the landscape of the global life-sciences sector, Swedish private equity giant EQT has reached...
In a monumental development that reshapes the landscape of the global life-sciences sector, Swedish private equity giant EQT has reached...
Hantaviruses have long been recognized as formidable threats to human health. While many hantaviruses are transmitted primarily through contact with...
Executive Summary: A Paradigm Shift in Oncology In a landmark development for precision medicine, an international coalition of scientists has...
In a groundbreaking convergence of bioengineering, electrochemistry, and digital health, an international research team has unveiled a revolutionary device that...
By Tech & Science Editorial Desk Published: October 2023 Main Facts Imagine walking through a remote wilderness, pulling a sleek...
After four years of post-pandemic stagnation, the biotechnology sector has finally emerged from its winter. As of late 2026, the...
By Jason Jabbour, Kai Kleinbard, and Vijay Janapa Reddi (Harvard University) In the fast-paced world of artificial intelligence, a pervasive...
For decades, the medical community and the general public have operated under a pervasive assumption: once a woman reaches menopause,...
In an industry where the sheer volume of biological data threatens to outpace the tools available to interpret it, Illumina...
In the decades-long battle against Alzheimer’s disease, the scientific community has largely fixated on a single, stubborn adversary: the extracellular...
By Tech & Innovation Desk Published: September 2026 Main Facts: The Physics of an Instantaneous Illusion For nearly two decades,...
In a development that has sent shockwaves through the biotech sector, Caribou Biosciences (Nasdaq: CRBU)—the Berkeley-based genome-editing powerhouse co-founded by...